{"product_id":"covetrus-pestle-analysis","title":"Covetrus PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSkip the Research. Get the Strategy.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eGet actionable insight into how political shifts, economic pressures, and tech disruption are shaping Covetrus’s prospects—our concise PESTLE highlights risks and opportunities to inform investment and strategy decisions; purchase the full analysis for the complete, editable report and immediate use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Trade Agreements\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eShifts in global trade deals affect Covetrus’s sourcing costs and availability of pharmaceuticals and medical supplies; in 2024 cross-border logistics disruptions raised procurement costs by an estimated 6–8%, pressuring margins in distribution.\u003c\/p\u003e\n\u003cp\u003eCovetrus depends on a stable international supply chain to serve clinics across North America, Europe and APAC, where inventory turns averaged about 4.2x in 2024.\u003c\/p\u003e\n\u003cp\u003eAs of late 2025, new tariffs and export restrictions could change distribution segment gross margins materially—historically a 5% tariff lift would erode segment margins by roughly 150–250 basis points given 2024 cost structure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Animal Health Initiatives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePublic funding for zoonotic disease prevention and livestock health—estimated at over $4.2 billion globally in 2024 for animal health programs—directly boosts demand for veterinary services, benefiting Covetrus’ distribution and digital offerings. As governments ramp up biosecurity and food-safety spending, Covetrus can expand sales of tracking and diagnostic tools; public-sector procurement accounted for roughly 18% of veterinary market spend in 2024, driving large-scale contracts for tech and medical supplies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare Policy for Pets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePotential policy shifts aligning veterinary regulation with human medicine—such as stricter controlled‑substance rules or expanded reporting—could raise compliance costs for Covetrus, which reported $4.3B revenue in 2024 and relies on pharmacy services for margin stability; political pressure for prescription transparency (e.g., real‑time PDMP integration mandates in 18 US states by 2025) directly affects its Rx management software and fulfillment workflows.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical Stability in Key Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePolitical unrest in LATAM and parts of APAC could disrupt Covetrus logistics and veterinary supply chains, risking shipment delays and higher operating costs; 2024 trade disruptions raised global freight rates ~15% YoY, affecting margins.\u003c\/p\u003e\n\u003cp\u003eNorth America and Europe, accounting for roughly 70% of Covetrus 2024 revenue, remain core for stable cash flow, while expansion into emerging markets offers CAGR upside but higher political risk.\u003c\/p\u003e\n\u003cp\u003eStrategic planning must model regional volatility scenarios—including infrastructure delays and supply interruptions—to protect inventory turnover and service SLAs.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~70% revenue from NA\/EU in 2024\u003c\/li\u003e\n\u003cli\u003eGlobal freight rates +15% YoY (2024)\u003c\/li\u003e\n\u003cli\u003eEmerging markets = growth + higher political risk\u003c\/li\u003e\n\u003cli\u003ePlan for supply-chain disruption scenarios\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePet Ownership Legislation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eLocal and national pet ownership laws and breed-specific bans shape Covetrus's TAM; in the US, 67% of households owned a pet in 2023, supporting a $136B pet care market, but breed restrictions in some states reduce addressable clients.\u003c\/p\u003e\n\u003cp\u003eAdoption incentives and tax breaks—several US cities offered pet-related tax deductions in 2024—increase demand for veterinary supplies and services Covetrus supplies.\u003c\/p\u003e\n\u003cp\u003eRestrictive pet policies in dense urban centers (rental bans affecting ~20% of US rental units) constrain market expansion and recurring revenue opportunities.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e67% US pet ownership (2023); $136B pet market (2023)\u003c\/li\u003e\n\u003cli\u003eAdoption\/tax incentives in select jurisdictions boost demand\u003c\/li\u003e\n\u003cli\u003eRental pet bans impact ~20% of rental units, limiting urban growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCovetrus margins squeezed by political risk, rising freight (+15%) and 6–8% procurement costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical risks—trade policy, tariffs, biosecurity funding, controlled‑substance regulation and regional unrest—directly affect Covetrus margins, supply chains and addressable market; NA\/EU contributed ~70% of $4.3B revenue in 2024, global freight +15% YoY and procurement costs rose ~6–8% in 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue (Covetrus)\u003c\/td\u003e\n\u003ctd\u003e$4.3B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNA\/EU share\u003c\/td\u003e\n\u003ctd\u003e~70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFreight rates YoY\u003c\/td\u003e\n\u003ctd\u003e+15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcurement cost rise\u003c\/td\u003e\n\u003ctd\u003e6–8% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic animal‑health funding\u003c\/td\u003e\n\u003ctd\u003e$4.2B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect Covetrus across six dimensions—Political, Economic, Social, Technological, Environmental, and Legal—backed by current data and trends to identify threats and opportunities for executives and investors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eSummarizes Covetrus’s external environment by PESTLE category for quick reference in meetings, enabling fast alignment on regulatory, technological, and market risks and opportunities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResilience of Pet Care Spending\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePet care spending proved resilient in 2024–25, with US pet healthcare expenditure rising ~5.4% year-over-year to an estimated $36.4bn in 2024, supporting Covetrus’s inelastic demand for essentials and prescriptions which represent ~60% of its sales mix.\u003c\/p\u003e\n\u003cp\u003eNonetheless, persistent inflation in 2024 (core CPI ~4.0% annual) prompted increased uptake of generics, pressuring margins as lower-cost alternatives captured a growing share of prescription volumes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLabor Market Dynamics in Veterinary Medicine\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePersistent shortages in veterinary staff—AVMA reported a 2024 vacancy rate of about 12% for technicians and 8% for veterinarians—constrain clinic capacity to fully adopt Covetrus software and services. Rising wages, with median vet technician pay up 6% YoY to roughly $39,000 in 2024 and veterinarian salaries rising ~5% to a median near $120,000, increase operating costs for Covetrus’s customers. These cost pressures accelerate demand for Covetrus automation and efficiency tools to offset labor expense growth and preserve margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterest Rate Environment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigh US interest rates — with the Federal Reserve policy rate near 5.25–5.50% in 2024–2025 — constrain veterinary clinics’ borrowing for tech upgrades and expansions, reducing addressable spend on Covetrus’s practice management software.\u003c\/p\u003e\n\u003cp\u003eIndependent clinics, which account for a large share of demand, face higher loan costs and tighter capex: small business lending rates rose roughly 200–300 basis points versus 2021–2022.\u003c\/p\u003e\n\u003cp\u003eCovetrus’s own floating-rate debt and planned M\u0026amp;A are exposed to rate volatility, increasing debt servicing costs and potentially delaying acquisitions or pushing toward more cash-conservative strategies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Currency Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAs a global entity, Covetrus faces exchange-rate risk that trimmed FY2024 reported revenue by an estimated 2-3% (~$30–45m) when the US dollar strengthened versus the euro and pound.\u003c\/p\u003e\n\u003cp\u003eDollar moves can erode international price competitiveness and margins in EMEA; a 5% USD appreciation typically reduces foreign-currency revenue translated to USD materially.\u003c\/p\u003e\n\u003cp\u003eRobust hedging—forwards, options, natural hedges—remains essential to stabilize earnings and cashflow.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFY2024 FX headwind ~2–3% of revenue (~$30–45m)\u003c\/li\u003e\n\u003cli\u003e5% USD appreciation materially lowers translated revenue\u003c\/li\u003e\n\u003cli\u003eHedging via forwards\/options and operational natural hedges recommended\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsumer Disposable Income\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpwhile pet care remains resilient elective surgeries and premium wellness plans are sensitive to household budgets us real disposable personal income fell month-over-month in dec which could reduce clinic visits lower covetrus supply volumes.\u003e\n\u003cpmonitoring consumer confidence conference board index at in jan vs forecast demand for high-margin specialty products and premium software features.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDisposable income dip can cut elective service volumes\u003c\/li\u003e\n\u003cli\u003eLower clinic visits reduce supply chain throughput\u003c\/li\u003e\n\u003cli\u003eConsumer confidence decline signals weaker premium product uptake\u003c\/li\u003e\n\u003cli\u003eTrack confidence and income monthly to adjust inventory and pricing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pmonitoring\u003e\u003c\/pwhile\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCovetrus buoyed by pet care spend and automation demand amid margin, labor, and FX pressure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePet care spend rose ~5.4% YoY to $36.4bn in 2024 supporting Covetrus’s inelastic essentials (~60% sales), but 2024 core CPI ~4.0% drove generic uptake and margin pressure; vet labor shortages (tech vac 12%, vet vac 8%) and pay inflation (tech +6% to $39k, vet +5% to $120k) boost demand for automation. Fed rate ~5.25–5.50% raises borrowing costs and debt servicing; FY2024 FX headwind ~2–3% (~$30–45m).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS pet healthcare spend\u003c\/td\u003e\n\u003ctd\u003e$36.4bn (+5.4%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCore CPI\u003c\/td\u003e\n\u003ctd\u003e~4.0%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVet tech vacancy\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVet vacancy\u003c\/td\u003e\n\u003ctd\u003e~8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFed policy rate\u003c\/td\u003e\n\u003ctd\u003e5.25–5.50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFX headwind\u003c\/td\u003e\n\u003ctd\u003e~2–3% ($30–45m)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eCovetrus PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Covetrus PESTLE Analysis you’ll receive after purchase—fully formatted, professionally structured, and ready to use.\u003c\/p\u003e\n\u003cp\u003eNo placeholders or teasers: the layout, content, and structure visible here are exactly what you’ll be able to download immediately after payment.\u003c\/p\u003e\n\u003cp\u003eEverything displayed in this preview is part of the final file, so there are no surprises—what you see is what you’ll get.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751521071481,"sku":"covetrus-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/covetrus-pestle-analysis.png?v=1772232531","url":"https:\/\/matrixbcg.com\/products\/covetrus-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}